Perniosis in the COVID-19 era

0Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and the most common symptoms include fever, dry cough, dyspnea, fatigue, anorexia, ageusia, and anosmia. Cutaneous manifestations are less common and we share our experience with an otherwise healthy and asymptomatic young man. The patient presented with painless acrocyanosis of the left toes which progressed to desquamation by day 16 of disease onset. Disease progression is documented via multiple photographs that portray progression of disease and subsequent resolution over approximately six weeks. Symptomatic treatment included non-steroidal anti-inflammatory medications, leg elevation, and warm compresses.

Cite

CITATION STYLE

APA

Shah, I., Stacey, S. K., Ganne, N., & Merfeld, J. (2021). Perniosis in the COVID-19 era. Dermatology Online Journal, 27(5). https://doi.org/10.5070/D327553625

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free